✦ LIBER ✦

Identification of novel small molecule TGF-β antagonists using structure-based drug design

✍ Scribed by Wang, Hao; Sessions, Richard B.; Prime, Stephen S.; Shoemark, Deborah K.; Allen, Shelley J.; Hong, Wei; Narayanan, Sathya; Paterson, Ian C.

Book ID: 120331501
Publisher: Springer Netherlands
Year: 2013
Tongue: English
Weight: 707 KB
Volume: 27
Category: Article
ISSN: 0920-654X
DOI: 10.1007/s10822-013-9651-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of Novel Short Chain 4-Su

Identification of Novel Short Chain 4-Substituted Indoles as Potent ανβ3 Antagonist Using Structure-Based Drug Design.

✍ Pierre Raboisson; Renee L. DesJarlais; Rolanda Reed; Jennifer Lattanze; Margery 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 14 KB

Identification and mapping of small-mole

Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design

✍ Christoph Sotriffer; Gerhard Klebe 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Identification and Mapping of Small-Mole

Identification and Mapping of Small-Molecule Binding Sites in Proteins: Computational Tools for Structure-Based Drug Design.

✍ Christoph Sotriffer; Gerhard Klebe 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 4 views

Identification of Potent and Selective S

Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design

✍ DeLano, Warren L.; Fahr, Bruce; Choong, Ingrid C.; Lew, Willard; Lee, Dennis; Ph 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 651 KB

Novel, Potent Small-Molecule Inhibitors

Novel, Potent Small-Molecule Inhibitors of the Molecular Chaperone Hsp90 Discovered through Structure-Based Design

✍ Dymock, Brian W.; Barril, Xavier; Brough, Paul A.; Cansfield, Julie E.; Massey, 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 161 KB

592 Characterisation of novel, small mol

592 Characterisation of novel, small molecule antagonists of XIAP, cIAP1 and cIAP2 generated by fragment based drug discovery (FBDD)

✍ G. Ward; G. Chessari; A. Woolford; P. Williams; K. Hearn; C. Richardson; J. Coyl 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB